Antistaphylococcal Betalactam and Emergence of Resistance (CePasR)

Central Hospital, Nancy, France

Status: Completed

Conditions: Bacterial Resistance; Methicillin-Sensitive Staphylococcus Aureus Infection

Study type: Observational

Funder types: Other

Identifiers

NCT05939479

2023PI051

Details and patient eligibility

About

Antistaphylococcal penicillins are recommanded as first-line agent in methicillin-suceptible Staphylococcus aureus bacteraemia. Several studies in progress are investigating the efficacy and safety of cefazolin compared with antistaphylococcal penicillins. Cefazolin has broader spectrum than antistaphylococcal penicillins. The hypothesis of this project is that cefazoline could be responsible for a higher rate of bacterial resistance. The aim is to study the association between the emergence of bacterial resistance and the consumption of cefazolin and antistaphylococcal penicillins.

Enrollment: 644 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: French hospitals which have collected their consumption and resistance data on the French national database named CONSORES (From 2019 to 2022)

Exclusion Criteria:

• None